Quantitative evaluation of siRNA delivery in vivo

RNA

Volumn 16, Issue 12, 2010, Pages 2553-2563

  Pei, Yi ^a   Hancock, Paula J ^a   Zhang, Hangchun ^a   Bartz, René ^a   Cherrin, Craig ^a   Innocent, Nathalie ^a   Pomerantz, Colin J ^a   Seitzer, Jessica ^a   Koser, Martin L ^a   Abrams, Marc T ^a   Xu, Yan ^a   Kuklin, Nelly A ^a   Burke, Paul A ^a   Sachs, Alan B ^a   Sepp Lorenzino, Laura ^a   Barnett, Stanley F ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Argonaute 2; In vivo delivery; RISC; siRNA

Indexed keywords

SMALL INTERFERING RNA;

ANIMAL TISSUE; ARTICLE; CELL LYSATE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; MONKEY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODIES; ANTIBODY SPECIFICITY; CELLS, CULTURED; EUKARYOTIC INITIATION FACTOR-2; EVALUATION STUDIES AS TOPIC; FEMALE; GENE SILENCING; GENE TARGETING; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOPRECIPITATION; MACACA MULATTA; MICE; MICE, INBRED ICR; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; RODENTIA;

ANIMALIA; RODENTIA;

EID: 78649683035     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.2255810     Document Type: Article

References (46)

1. Abrams MT, Koser ML, Seitzer J, Williams SC, DiPietro MA, Wang W, Shaw AW, Mao X, Jadhav V, Davide JP, et al. 2010. Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: Effect of dexamethasone co-treatment. Mol Ther 18: 171-180.
2. Ameres SL, Martinez J, Schroeder R. 2007. Molecular basis for target RNA recognition and cleavage by human RISC. Cell 130: 101-112.
3. Azuma-Mukai A, Oguri H, Mituyama T, Qian ZR, Asai K, Siomi H, Siomi MC. 2008. Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing. Proc Natl Acad Sci 105: 7964-7969. (Pubitemid 351904690)
4. Bartel DP. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233.
5. Beitzinger M, Peters L, Zhu JY, Kremmer E, Meister G. 2007. Identification of human microRNA targets from isolated Argonaute protein complexes. RNA Biol 4: 76-84.
6. Carmell MA, Xuan Z, Zhang MQ, Hannon GJ. 2002. The Argonaute family: Tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes & Dev 16: 2733-2742. (Pubitemid 35253139)
7. Carthew RW, Sontheimer EJ. 2009. Origins and mechanisms of miRNAs and siRNAs. Cell 136: 642-655.
8. Castanotto D, Rossi JJ. 2009. The promises and pitfalls of RNA-interference-based therapeutics. Nature 457: 426-433.
9. Castanotto D, Sakurai K, Lingeman R, Li H, Shively L, Aagaard L, Soifer H, Gatignol A, Riggs A, Rossi JJ. 2007. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC. Nucleic Acids Res 35: 5154-5164. (Pubitemid 47394199)
10. Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bort R, et al. 2004. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 1: 106-113.
11. Chatterjee S, Grosshans H. 2009. Active turnover modulates mature microRNA activity in Caenorhabditis elegans. Nature 461: 546-549.
12. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al. 2005. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179. doi: 10.1093/nar/gni178.
13. Chen PY, Weinmann L, Gaidatzis D, Pei Y, Zavolan M, Tuschl T, Meister G. 2008. Strand-specific 5′-O-methylation of siRNA duplexes controls guide strand selection and targeting specificity. RNA 14: 263-274.
14. Cheng A, Li M, Liang Y, Wang Y, Wong L, Chen C, Vlassov AV, Magdaleno S. 2009. Stem-loop RT-PCR quantification of siRNAs in vitro and in vivo. Oligonucleotides 19: 203-208.
15. Czauderna F, Fechtner M, Dames S, Aygun H, Klippel A, Pronk GJ, Giese K, Kaufmann J. 2003. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res 31: 2705-2716.
16. Farazi TA, Juranek SA, Tuschl T. 2008. The growing catalog of small RNAs and their association with distinct Argonaute/Piwi family members. Development 135: 1201-1214. (Pubitemid 351622465)
17. Ghildiyal M, Zamore PD. 2009. Small silencing RNAs: An expanding universe. Nat Rev Genet 10: 94-108.
18. Hutvágner G, Simard MJ, Mello CC, Zamore PD. 2004. Sequence-specific inhibition of small RNA function. PLoS Biol 2: E98. doi: 10.1371/journal.pbio.0020098.
19. Hwang HW, Wentzel EA, Mendell JT. 2009. Cell-cell contact globally activates microRNA biogenesis. Proc Natl Acad Sci 106: 7016-7021.
20. Jinek M, Doudna JA. 2009. A three-dimensional view of the molecular machinery of RNA interference. Nature 457: 405-412.
21. John M, Constien R, Akinc A, Goldberg M, Moon YA, Spranger M, Hadwiger P, Soutschek J, Vornlocher HP, Manoharan M, et al. 2007. Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway. Nature 449: 745-747.
22. Khan AA, Betel D, Miller ML, Sander C, Leslie CS, Marks DS. 2009. Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat Biotechnol 27: 549-555.
23. Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ, Albuquerque RJ, Yamasaki S, Itaya M, Pan Y, et al. 2008. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452: 591-597.
24. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-Tor L, Hannon GJ. 2004. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305: 1437-1441. (Pubitemid 39167657)
25. McManus MT, Haines BB, Dillon CP, Whitehurst CE, van Parijs L, Chen J, Sharp PA. 2002. Small interfering RNA-mediated gene silencing in T lymphocytes. J Immunol 169: 5754-5760. (Pubitemid 35291677)
26. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T. 2004. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 15: 185-197.
27. Mescalchin A, Detzer A, Wecke M, Overhoff M, Wunsche W, Sczakiel G. 2007. Cellular uptake and intracellular release are major obstacles to the therapeutic application of siRNA: Novel options by phosphorothioate-stimulated delivery. Expert Opin Biol Ther 7: 1531-1538.
28. Mili S, Steitz JA. 2004. Evidence for reassociation of RNA-binding proteins after cell lysis: Implications for the interpretation of immunoprecipitation analyses. RNA 10: 1692-1694.
29. Miyoshi K, Uejima H, Nagami-Okada T, Siomi H, Siomi MC. 2008. In vitro RNA cleavage assay for Argonaute-family proteins. Methods Mol Biol 442: 29-43.
30. Morin A, Gallou-Kabani C, Mathieu JR, Cabon F. 2009. Systemic delivery and quantification of unformulated interfering RNAs in vivo. Curr Top Med Chem 9: 1117-1129.
31. Morrissey DV, Lockridge JA, Shaw L, Blanchard K, Jensen K, Breen W, Hartsough K, Machemer L, Radka S, Jadhav V, et al. 2005. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 23: 1002-1007.
32. Nykanen A, Haley B, Zamore PD. 2001. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107: 309-321. (Pubitemid 33049975)
33. Peer D, Park EJ, Morishita Y, Carman CV, Shimaoka M. 2008. Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science 319: 627-630. (Pubitemid 351197066)
34. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. 2003. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115: 199-208. (Pubitemid 37329583)
35. Sepp-Lorenzino L, Ruddy M. 2008. Challenges and opportunities for local and systemic delivery of siRNA and antisense oligonucleotides. Clin Pharmacol Ther 84: 628-632.
36. Stratford S, Stec S, Jadhav V, Seitzer J, Abrams M, Beverly M. 2008. Examination of real-time polymerase chain reaction methods for the detection and quantification of modified siRNA. Anal Biochem 379: 96-104.
37. Svensson RU, Shey MR, Ballas ZK, Dorkin JR, Goldberg M, Akinc A, Langer R, Anderson DG, Bumcrot D, Henry MD. 2008. Assessing siRNA pharmacodynamics in a luciferase-expressing mouse. Mol Ther.16: 1995-2001.
38. Tomari Y, Du T, Haley B, Schwarz DS, Bennett R, Cook HA, Koppetsch BS, Theurkauf WE, Zamore PD. 2004. RISC assembly defects in the Drosophila RNAi mutant armitage. Cell 116: 831-841. (Pubitemid 38410728)
39. Tseng YC, Mozumdar S, Huang L. 2009. Lipid-based systemic delivery of siRNA. Adv Drug Deliv Rev 61: 721-731.
40. Veldhoen S, Laufer SD, Trampe A, Restle T. 2006. Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: Quantitative analysis of uptake and biological effect. Nucleic Acids Res 34: 6561-6573. (Pubitemid 46017951)
41. Wang B, Li S, Qi HH, Chowdhury D, Shi Y, Novina CD. 2009. Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins. Nat Struct Mol Biol 16: 1259-1266.
42. Whitehead KA, Langer R, Anderson DG. 2009. Knocking down barriers: Advances in siRNA delivery. Nat Rev Drug Discov 8: 129-138.
43. Wolin SL, Cedervall T. 2002. The La protein. Annu Rev Biochem 71: 375-403.
44. Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA, Manjunath N. 2007. miRNA profiling of naive, effector and memory CD8 T cells. PLoS ONE 2: e1020. doi: 10.1371/journal.pone.0001020.
45. Wu L, Fan J, Belasco JG. 2008. Importance of translation and nonnucleolytic ago proteins for on-target RNA interference. Curr Biol 18: 1327-1332.
46. Yoda M, Kawamata T, Paroo Z, Ye X, Iwasaki S, Liu Q, Tomari Y. 2010. ATP-dependent human RISC assembly pathways. Nat Struct Mol Biol 17: 17-23.